Optimization of Marine Triterpene Sipholenols as Inhibitors of Breast Cancer Migration and Invasion

ChemMedChem

Volumn 8, Issue 3, 2013, Pages 497-510

  Foudah, Ahmed I ^a   Jain, Sandeep ^a,b   Busnena, Belnaser A ^a   ElSayed, Khalid A ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b Sun Pharma Advanced Research Company   (India)

Author keywords

Antimigratory agents; Breast cancer; PTK6; SipholenolA; Structure activity relationships

Indexed keywords

10,11,19,20 DIANHYDROSIPHOLENOL A; 19,20 ANHYDROSIPHOLENOL A 4BETA 4 CHLOROBENZOATE; 4,19BETA O DIACETYLSIPHOLENOL A; 4BETA O 4' CHLOROBENZOYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O 4' CHLOROBENZOYLSIPHOLENOL A; 4BETA O 4' METHYLBENZOYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O 4' METHYLBENZOYLSIPHOLENOL A; 4BETA O ACETYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O ACETYLSIPHOLENOL A; 4BETA O BENZOYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O BENZOYLSIPHOLENOL A; 4BETA O BENZYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O BENZYLCARBAMOYLSIPHOLENOL A; 4BETA O BENZYLSIPHOLENOL A; 4BETA O ISONICOTINOYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O ISONICOTINOYLSIPHOLENOL A; 4BETA O SUCCINYL 19,20 ANHYDROSIPHOLENOL A; 4BETA O SUCCINYLSIPHOLENOL A; 4BETA O TOSYLCARBAMOYLSIPHOLENOL A; ANTINEOPLASTIC AGENT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 6; SIPHOLENOL A; SIPHOLENOL A 4BETA 4 CHLOROBENZOATE; SIPHOLENONE A; SIPHOLENONE A N BENZOYLOXIME; SIPHOLENONE A N BENZYLOXIME; SIPHOLENONE A OXIME; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MASS SPECTROMETRY; METASTASIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CALLYSPONGIA; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 84874341185     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201200516     Document Type: Article

References (35)

1. T. L. Simmons, E. Andrianasolo, K. McPhail, P. Flatt, W. H. Gerwick, Mol. Cancer Ther. 2005, 4, 333-342.
2. R. Singh, M. Sharma, P. Joshi, D. S. Rawat, Anti-Cancer Agents Med. Chem. 2008, 8, 603-617.
3. I. Ojima, J. Med. Chem. 2008, 51, 2587-2588.
4. D. J. Newman, G. M. Cragg, J. Nat. Prod. 2012, 75, 311-335.
5. D. J. Newman, G. M. Cragg, J. Nat. Prod. 2004, 67, 1216-1238.
6. S. Carmely, Y. Kashman, J. Org. Chem. 1983, 48, 3517-3525.
7. S. Carmely, Y. Kashman, J. Org. Chem. 1986, 51, 784-788.
8. Y. Kashman, T. Yosief, S. Carmely, J. Nat. Prod. 2001, 64, 175-180.
9. S. Jain, I. Abraham, P. Carvalho, Y.-H. Kuang, D. T. A. Youssef, M. A. Avery, Z. S. Chen, K. A. ElSayed, J. Nat. Prod. 2009, 72, 1291-1298.
10. I. Abraham, S. Jain, C. P. Wu, Y. Kuanga, Z. Shia, X. Chen, M. Khanfar, L. Fu, S. V. Ambudkar, K. A. ElSayed, Z. S. Chen, Biochem. Pharmacol. 2010, 80, 1497-1506.
11. S. Jain, S. Laphookhieo, Z. Shi, L. Fu, S. Akiyama, Z. S. Chen, D. T. A. Youssef, R. W. M. vanSoest, K. A. ElSayed, J. Nat. Prod. 2007, 70, 928-931;
12. S. Jain, A. Shirode, S. Yacoub, A. Barbo, P. W. Sylvester, E. Huntimer, F. Halaweish, K. A. ElSayed, Planta Med. 2007, 73, 591-596.
13. G. Szakács, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, M. M. Gottesman, Nat. Rev. Drug Discovery 2006, 5, 219-234.
14. V. Höll, M. Kouba, M. Dietel, G. Vogt, Biochem. Pharmacol. 1992, 43, 2601-2608.
15. http://www.cancer.org/research/cancerfactsfigures/index (accessed October 20, 2012); American Cancer Society Statistics for 2011-2012.
16. K. T. Barker, L. E. Jackson, Oncogene 1997, 15, 799-805.
17. P. J. Mitchell, K. T. Barker, J. E. Martindale, T. Kamalati, P. N. Lowe, M. J. Page, B. A. Gusterson, M. R. Crompton, Oncogene 1994, 9, 2383-2390.
18. M. Aubele, G. Auer, A. K. Walch, A. Munro, M. J. Atkinson, H. Braselmann, Br. J. Cancer 2007, 96, 801-807.
19. P. J. Mitchell, K. T. Barker, J. Shipley, M. R. Crompton, Oncogene 1997, 15, 1497-1502.
20. A. J. Harvey, C. J. Pennington, S. Porter, R. S. Burmi, D. R. Edwards, W. Court, Am. J. Pathol. 2009, 175, 1226-1234.
21. P. M. Brauer, A. L. Tyner, Biochim. Biophys. Acta Rev. Cancer 2010, 1806, 66-73.
22. A. Rudi, M. Aknin, E. M. Gaydou, Y. Kashman, J. Nat. Prod. 1997, 60, 700-703.
23. A. Rudi, I. Goldberg, Z. Stein, Y. Kashman, Y. Benayahu, M. Schleyer, J. Nat. Prod. 1995, 58, 1702-1712.
24. I. Carletti, C. Long, C. Funel, P. Amade, J. Nat. Prod. 2003, 66, 25-29.
25. C. Funel-Le Bon, F. Berrué, O. P. Thomas, F. Reyes, P. Amade, J. Nat. Prod. 2005, 68, 1284-1287.
26. J. Dai, J. A. Fishback, Y. D. Zhou, D. G. Nagle, J. Nat. Prod. 2006, 69, 1715-1720.
27. M. Mudit, M. Khanfar, A. Muralidharan, S. Thomas, G. V. Shah, R. W. vanSoest, K. A. ElSayed, Bioorg. Med. Chem. 2009, 17, 1731-1738.
28. L. G. Rodriguez, X. Wu, J. L. Guan, Methods Mol. Biol. 2005, 294, 23-29.
29. Cultrex BME cell invasion assay protocol, Trevigen Inc., Gaithersburg, MD, USA; http://www.trevigen.com (accessed on September 15, 2012).
30. M. A. Khanfar, D. T. A. Youssef, K. A. ElSayed, ChemMedChem 2010, 5, 274-285.
31. TACS MTT Cell proliferation assays protocol, Trevigen Inc., Gaithersburg, MD, USA; http://www.trevigen.com (accessed on May 22, 2011).
32. T. Mosmann, J. Immunol. Methods 1983, 65, 55-63.
33. S. M. Rodems, B. D. Hamman, C. Lin, J. Zhao, S. Shah, D. Heidary, L. Makings, J. H. Stack, B. A. Pollok, Assay Drug Dev. Technol. 2002, 1, 9-19.
34. F. A. Behery, A. Y. Elnagar, M. R. Akl, V. B. Wali, B. Abuasal, A. Kaddoumi, P. W. Sylvester, K. A. ElSayed, Bioorg. Med. Chem. 2010, 18, 8066-8075.
35. H. M. Hassan, A. Y. Elnagar, M. A. Khanfar, A. A. Sallam, R. Mohammed, L. A. Shaala, T. D. Diaa, S. M. Hifnawy, K. A. ElSayed, Eur. J. Med. Chem. 2011, 46, 1122-1130.